Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...

AstraZeneca PLC closed 20.36% short of its 52-week high of £133.88, which the company achieved on September 3rd.

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move ...

Astrazeneca (AZN) closed the most recent trading day at $73.55, moving -1.17% from the previous trading session. The stock's ...

Head Ali El-Ghamrawy has met with AstraZeneca Egypt Country President Hatem El-Werdany to discuss ways to boost collaboration ...

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in ...

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Virtual. About Innate Pharma. Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunothera ...

Another Cambridge UK life science company has expanded its trade reach into China as a new Silk Road of trade re-opens.